Short answer · Medically reviewed summary · Last updated: 2026-04-06
Fibromyalgia was formally defined in its modern sense in 1976 by Dr. Harvey Moldofsky, though historical descriptions of widespread musculoskeletal pain date back to the early 19th century. From "Muscular Rheumatism" to Fibromyalgia In the 1800s, physicians often referred to widespread pain as "muscular rheumatism." In 1904, Sir William Gowers coined the term "fibrositis," theorizing that the condition was an inflammation of the fibrous tissues.
7 people with Fibromyalgia have shared their first-person experience on this question at DiseaseMaps.
Fibromyalgia was formally defined in its modern sense in 1976 by Dr. Harvey Moldofsky, though historical descriptions of widespread musculoskeletal pain date back to the early 19th century.
In the 1800s, physicians often referred to widespread pain as "muscular rheumatism." In 1904, Sir William Gowers coined the term "fibrositis," theorizing that the condition was an inflammation of the fibrous tissues. However, later biopsies failed to show consistent inflammation, leading to decades of medical skepticism regarding the validity of Fibromyalgia as a distinct biological disorder.
The 1970s marked a pivotal shift when Dr. Harvey Moldofsky discovered the link between Fibromyalgia and non-restorative sleep, specifically identifying alpha-delta sleep anomalies. In 1990, the American College of Rheumatology (ACR) established the first formal diagnostic criteria based on "tender points," which provided a standardized framework for research. By 2010, the criteria evolved to prioritize widespread pain and systemic symptoms like cognitive impairment and fatigue, moving away from the focus on tender points.
Historically, patients faced significant stigma, with many being told their symptoms were purely psychological. Patient advocacy groups, such as the National Fibromyalgia & Chronic Pain Association, were instrumental in shifting the narrative toward neurobiology. Today, we understand Fibromyalgia as a disorder of central sensitization, where the central nervous system amplifies pain signals. Advances in functional MRI (fMRI) technology have allowed researchers to visualize these altered pain-processing pathways in the brain, providing objective evidence for what patients have long reported.
Treatment has transitioned from simple analgesics to a multidisciplinary approach. A major milestone occurred in 2007 when the FDA approved the first medication specifically for Fibromyalgia, acknowledging the role of neurotransmitters like serotonin and norepinephrine in pain modulation. Modern care now emphasizes a holistic strategy combining physical therapy, cognitive behavioral therapy, and evidence-based pharmacotherapy.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.